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1. Introduction
Chitosan is a deacetylated derivative of chitin
which is a water insoluble polymer, (N-acetyl-d-
glucosamine) found in nature, present in insect
exoskeletons, outer shells of crabs, shrimps, lob-
sters etc. and fungal cell walls. It has been exten-
sively studied as a carrier for drugs owing to its
biocompatibility and biodegradability [1–5]. Chi-
tosan based interpenetrating polymer networks
(IPNs) currently received enormous interest for
medical and pharmaceutical applications due to
their good biocompatibility, low degradation and
processing ease. The ability of these IPNs to swell
and dehydrate depend on composition and environ-
ment which has been exploited to facilitate a range
of applications such as drug release, its biodegrad-
ability and ability to form hydrogels [6].
Drug release from chitosan based IPNs can be con-
trolled by the matrix density, which is affected by
various factors, such as concentration of chitosan,
percentage of crosslinking agent, amount of drug
and response time [7–8]. However, quantitative
aspects of the effects and relationships among these
various factors have not been studied extensively.
The authors [9–10] have prepared semi-IPNs con-
sisting of chitosan-alanine and chitosan-glutamic
acid and studied their cure kinetics [11]. The bio-
compatibility is the reason behind the use of L-ala-
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spacer in the formation of semi-IPN. In order to
form semi-interpenetrating polymer network, two
chitosan polymer chains are crosslinked by glu-
taraldehyde. Amino groups of chitosan and alanine
can react with glutaraldehyde resulting in the
attachment of alanine in pendent form. Hence, the
resultant polymer system is characterized as semi-
IPN (one phase consists of crosslinked chitosan and
the other phase is made of alanine attached chi-
tosan).
Response surface methodology (RSM) is a collec-
tion of statistical and mathematical techniques, use-
ful for developing, improving and optimizing
processes [12–14]. It also has an important applica-
tion in the design, development and formulation of
new products as well as in the improvement of
existing product designs. The basic components of
response surface methodology include experimen-
tal design, regression analysis and optimization
algorithms which are used to investigate the empir-
ical relationship between one or more measured
responses and a number of independent variables,
with the ultimate goal of obtaining an optimal prob-
lem solution. RSM is a widely practiced approach
in the development and optimization of drug deliv-
ery devices [15–17]. Based on the principle of
design of experiments (DOE), the methodology
encompasses the use of various types of experi-
mental designs, generation of polynomial equa-
tions, and mapping of the response over the
experimental domain to determine the optimum
formulation(s) [18–21]. The technique requires
minimum experimentation and time, thus proving
to be far more effective and cost-effective than the
conventional methods of formulating dosage
forms.
The objectives are to investigate the effects of for-
mulation variables on the release of drug from
crosslinked chitosan-alanine beads and to optimize
the preparation of drug loaded chitosan-alanine
crosslinked beads for drug release using RSM.
Chlorpheniramine maleate (CPM), which is a
sedating antihistamine drug used for the sympto-
matic relief of allergic conditions, is selected as
model drug.
2. Materials and methods
2.1. Materials
Chitosan (percentage of deacetylation 80%; total
nitrogen: 7% minimum, ignition residue (sulfate):
<2% and loss on drying <15%) is procured from
Tokyo Kasei Kogyo Co., Ltd. Japan and used as
received. Chlorpheniramine maleate (CPM)
[C16H19ClN2C4H4O4] (pKa value = 9.4) is obtained
as a gift sample from Japson Pharmaceuticals Ltd.
Sangrur, India. Glutaraldehyde (C5H8O2) (MW =
100.11) 25% aqueous, acetic acid and L-alanine
[CH3CH(NH2)COOH] (MW = 89.09) are pur-
chased from CDH (New Delhi, India) and are of
analytical grade.
2.2. Experimental design
A central composite design (CCD) is employed to
fit a second order model. The levels are calculated
and experiments are performed using CCD
described elsewhere [22]. The four independent
formulation variables selected for this particular
study are the amount of chitosan (X1), the percent-
age of crosslinker i.e. glutaraldehyde (X2), the drug
loading level (X3) and the time of drug release (X4).
The weight of alanine is taken proportional to
weight of chitosan and all other parameters like 2%
acetic acid solution (20 ml), amount of crosslinker
(10 ml) and processing conditions such as tempera-
ture and drug release media (pH 2.0 and 7.4), are
kept invariant throughout the study. The amount of
drug release Y(2) and Y(7.4) in different pH solu-
tions (pH 2 and 7.4) are studied as the dependent
variables. The actual amounts and corresponding
coded values of different variables taken for the
design are reported in Table 1. The ranges of inde-
pendent variables are chosen on the basis of the
results obtained from the previous studies, con-
ducted in our laboratory [9]. The range of concen-
tration of chitosan is taken as 0.1–0.9 g/20 ml
beyond which, it becomes very difficult to extrude
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Table 1. Independent variables and their coded values for
the central composite design
Xi Independent variables
Coded values
–2 –1 0 1 2
X1 chitosan [g] 0.1 0.3 0.5 0.7 0.9
X2 glutaraldehyde (10 ml) [%] 0 6.25 12.5 18.8 25
X3 drug [mg] 25 50 75 100 125
X4 drug release time [hrs] 2 3 4 5 6the solution through the syringe due to the high vis-
cosity of the solution. At the same time, it is not
possible to prepare the beads without substantial
amount of chitosan. The drug release time is chosen
as 2 to 6 hrs because a burst release is observed in
the first hour and almost a plateau formation is
there after sixth hour of drug release. The concen-
tration of drug release Y(2) and Y(7.4) in pH solu-
tions of 2.0 and 7.4, respectively are selected as
response variables. Table 2 summarizes an account
of thirty experimental runs conducted during study.
The combinations of factors employed during the
study and their responses are given in Table 3. The
following second order model (Equation (1)) in X1,
X2, X3 and X4 is fitted using the data in Table 3:
Y(pH) = β0 + β1X1 + β2X2 + β3X3 + β4X4 +
β12X1X2 + β13X1X3 + β14X1X4 +
β23X2X3 + β24X2X4 + β34X3X4 +
β11X1
2 + β22X2
2 + β33X3
2 + β44X4
2 (1)
where β0 is the intercept representing the arithmetic
average of all quantitative outcomes of 30 runs; and
β1 to β44 are the coefficients computed from the
observed experimental values of Y; and Xi’s are the
coded independent variables. Statistical validity of
the polynomials is established on the basis of
ANOVA technique. Subsequently, the feasibility
and grid searches are performed to locate the com-
position of optimum formulations. The 2-D contour
plots for drug release in acidic and basic medium
are constructed using program developed in MAT-
LAB V.5. The formulations corresponding to the
design are prepared and evaluated for various
209
Kumari et al. – eXPRESS Polymer Letters Vol.3, No.4 (2009) 207–218
Table 2. Prepared formulations as per the experimental design
Formulation variables
Trial
No.
Chitosan
[g]
Glutaraldehyde (10 ml)
[%]
Drug (CPM)
[mg]
Response time
[hrs]
(X1) (X2) (X3) (X4)
F1 0.3 6.25 50 3
F2 0.7 6.25 50 3
F3 0.3 18.8 50 3
F4 0.7 18.8 50 3
F5 0.3 6.25 100 3
F6 0.7 6.25 100 3
F7 0.3 18.8 100 3
F8 0.7 18.8 100 3
F9 0.3 6.25 50 5
F10 0.7 6.25 50 5
F11 0.3 18.8 50 5
F12 0.7 18.8 50 5
F13 0.3 6.25 100 5
F14 0.7 6.25 100 5
F15 0.3 18.8 100 5
F16 0.7 18.8 100 5
F17 0.1 12.5 75 4
F18 0.9 12.5 75 4
F19 0.5 0 75 4
F20 0.5 25.0 75 4
F21 0.5 12.5 25 4
F22 0.5 12.5 125 4
F23 0.5 12.5 75 2
F24 0.5 12.5 75 6
F25 0.5 12.5 75 4
F26 0.5 12.5 75 4
F27 0.5 12.5 75 4
F28 0.5 12.5 75 4
F29 0.5 12.5 75 4
F30 0.5 12.5 75 4response properties. The resultant experimental
data of response properties are quantitatively com-
pared with that of the predicted values. Also, linear
regression plots between actual and predicted val-
ues of the response properties are drawn using
Microcal Origin 6.0, forcing the line to pass
through origin.
2.3. Preparation of chitosan-alanine beads
Table 1 enlists the central composition design of
different chitosan-alanine formulations prepared
using varying amounts of the chitosan, alanine, glu-
taraldehyde and drug. Drug loaded beads of chi-
tosan and alanine crosslinked with glutaraldehyde
are prepared, as reported earlier [9]. Briefly, a
known amount of CPM, chitosan and alanine are
dissolved in 2% acetic acid solution by stirring con-
ditions for three hours at room temperature. The
composition of various formulations is given in
Table 2. The homogeneous mixture is extruded in
the form of droplets using a 0.56 mm diameter
syringe into alkali–methanol solution (1:20 w/w)
under stirring conditions. The beads are washed
with hot and cold water, respectively. The resultant
beads were allowed to react with 10 ml of glu-
taraldehyde solution (25, 18.8, 12.5 and 6.25%) at
50°C for about 10 min for crosslinking. The forma-
tion of crosslinked chitosan-alanine semi-IPN
beads is shown in Figure 1. To form semi interpen-
etrating polymer network (semi-IPN), two chitosan
chains are crosslinked by glutaraldehyde. Amino
groups of chitosan and alanine can react with glu-
taraldehyde resulting in attachment of alanine in
pendent form. Finally, the crosslinked beads were
successively washed with hot and cold water and
air dried at 37°C. After cross-linking, the strength
of unreacted glutaraldehyde was determined by
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Table 3. Translation of actual units into coded levels and response for central composite design
Trial
No.
Chitosan Glutaraldehyde Drug (CPM) Response time Response (·10–4) [g/ml]
(X1) (X2) (X3) (X4) Y(2) Y(7.4)
F1 –1 –1 –1 –1 7.24 8.33
F2 1 –1 –1 –1 6.84 7.71
F3 –1 1 –1 –1 6.74 8.27
F4 1 1 –1 –1 6.47 7.63
F5 –1 –1 1 –1 7.62 9.02
F6 1 –1 1 –1 7.50 8.46
F7 –1 1 1 –1 6.92 8.60
F8 1 1 1 –1 6.69 8.18
F9 –1 –1 –1 1 7.75 8.99
F10 1 –1 –1 1 7.16 8.32
F11 –1 1 –1 1 7.66 8.51
F12 1 1 –1 1 6.83 8.29
F13 –1 –1 1 1 8.25 9.35
F14 1 –1 1 1 7.94 8.61
F15 –1 1 1 1 7.54 8.86
F16 1 1 1 1 7.10 8.52
F17 –2 0 0 0 6.83 8.43
F18 2 0 0 0 6.10 7.34
F19 0 –2 0 0 9.16 9.92
F20 0 2 0 0 6.97 9.02
F21 0 0 –2 0 6.33 7.81
F22 0 0 2 0 7.89 9.48
F23 0 0 0 –2 6.24 8.69
F24 0 0 0 2 7.97 9.67
F25 0 0 0 0 7.40 9.01
F26 0 0 0 0 7.40 9.02
F27 0 0 0 0 7.40 9.01
F28 0 0 0 0 7.40 9.01
F29 0 0 0 0 7.41 8.98
F30 0 0 0 0 7.38 9.02Brady’s reagent. The strength of residual glu-
taraldehyde, obtained after crosslinking the beads
was in the range of 2–3.5%. In other words, more
than 96% of glutaraldehyde was consumed during
the crosslinking process and hence, a highly
crosslinked structure was obtained.
2.4. In vitro drug release studies
The drug release experiments are performed in
acidic and basic medium (30 ml each) for all the
formulation combinations as reported elsewhere
[9]. Briefly, the drug release experiments are per-
formed in a glass apparatus at 37°C under unstirred
conditions. Out of the prepared beads only 0.2 g are
taken for the drug release studies which contain
approximately 5, 10, 15, 20 and 25 mg of CPM
drug, respectively. Different pH solutions (pH = 2
and pH = 7.4) are used as the drug release medium,
and the samples of 3 ml are withdrawn periodically
at predefined time intervals and analyzed under UV
spectrophotometer at 193.5 nm. All the release
experiments are carried out in triplicate and the
average results are reported. In order to maintain
nearly constant release environment and to get the
cumulative drug release concentration, the samples
withdrawn for the record of absorbance are imme-
diately added back to the release medium after
recording the absorbance. Drug release data are
analyzed using ANOVA software.
3. Results and discussion
Semi-IPN beads of chitosan and L-alanine are
formed by using glutaraldehyde as crosslinker. Ala-
nine acts as a spacer between the chitosan polymer
chains. The presence of alanine increases the void
content of the semi-IPN and thus, lowers the ten-
dency of ‘blocking’ effect of glutaraldehyde. It is
further believed that due to the presence of a
spacer, it is easier for the crosslinker to penetrate
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Figure 1. Schematic representation of crosslinking of chi-
tosan and L-alanine by glutaraldehyde for the
formation of interpenetrating network
Figure 2. a) and b) drug release profiles through acidic
medium from 30 formulations of chitosan-ala-
nine crosslinked beads prepared using experi-
mental designinto the core of the beads resulting in fully
crosslinked network.
In vitro drug release studies are performed in acidic
and basic environments. The crosslinked beads are
immersed in solutions of pH = 7.4 and pH = 2.0,
respectively. The dependence of drug release on
concentration of chitosan, degree of crosslinking
and nature of release environment is displayed in
Figures 2 and 3. It is observed during the drug
release experiments that the size of beads increases
as a result of diffusion of solvent. Due to increase
in the surface area of beads, the resistance to drug
transport increases which lowers the rate of drug
release in the latter part of study. Thirty experi-
ments are required for central composite design to
study the effect of various independent variables on
drug release. The designed formulations and the
observed responses for thirty experiments are given
in Table 3. The polynomial equations relating the
drug release responses Y(2) and Y(7.4) and inde-
pendent variables are (Equations (2) and (3)):
Y(2) = 7.4(±0.099) – 0.19(±0.049)X1 –
0.36(±0.049)X2 + 0.25(±0.049)X3 +
0.32(±0.049)X4 – 0.02(±0.06)X1X2 +
0.06(±0.06)X1X3 – 0.07(±0.06)X1X4 –
0.11(±0.06)X2X3 + 0.03(±0.06)X2X4 –
0.22(±0.046)X1
2 + 0.18(±0.046)X2
2 –
0.06(±0.046)X3
2 – 0.06(±0.046)X4
2 (2)
Y(7.4) = 9.01(±0.098) – 0.27(±0.049)X1 –
0.15(±0.049)X2 + 0.29(±0.049)X3 +
0.22(±0.049)X4 + 0.06(±0.06)X1X2 +
0.01(±0.06)X1X3 + 0.02(±0.06)X1X4 –
0.04(±0.06)X2X3 – 0.02(±0.06)X2X4 –
0.07(±0.06)X3X4 – 0.33(±0.046)X1
2 +
0.06(±0.046)X2
2 – 0.14(±0.046)X3
2 –
0.01(±0.046)X4
2 (3)
The Equations (2) and (3) represent the quantitative
effect of the independent variables (X1, X2, X3 and
X4) and their interactions on the responses Y(2) and
Y(7.4), respectively. Coefficients with more than
one factor term and those with higher order terms
represent interaction terms and quadratic relation-
ships, respectively. A positive sign represents a
synergistic effect, while a negative sign indicates
an antagonistic effect. The negative coefficients of
X1 and X2 in both the models refer to the decreasing
amount of drug release as the concentration of chi-
tosan and concentration of glutaraldehyde increases.
Similarly, the positive coefficients of X3 and X4
indicate the increase in drug release with increasing
concentration of drug and response time.
In order to check the reliability of the models to
predict drug release response four more experi-
ments, consisting of different values of variables
(X1, X2, X3 and X4) other than the design values, are
conducted. The theoretical values of drug release
are calculated using Equations (2) and (3). The the-
oretical and experimental values of drug release are
compared and are shown in Table 4. Comparison of
experimental and calculated values of drug release
response shows that the predicted models are in
reasonably good agreement with experimental data,
outside the design values. Table 5 presents the
ANOVA demonstrating that the model is signifi-
cant. The probability values, P< 0.0001 in ANOVA,
indicate significant effect of model on drug release
response.
Figure 4 indicates the effect of concentration of
chitosan, X1 and percentage of glutaraldehyde, X2
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Figure 3. a) and b) drug release profiles through basic
medium from 30 formulations of chitosan-ala-
nine crosslinked beads prepared using experi-
mental designon drug release in acidic Y(2) and basic Y(7.4)
media. In acidic medium, the drug release varies in
a nonlinear manner, but in a descending pattern
with an increase in concentration of chitosan and
percentage of crosslinker as shown in Figure 4a.
The contour plot shows that percentage of
crosslinker has a comparatively greater influence
on the drug release variable than concentration of
chitosan. ‘Saddle’ point is observed at X1 = 0.42 g
and X2 = 18.8%. Figure 4b indicates the effect of
simultaneous change in concentration of chitosan
and crosslinker on the drug release in basic medium
(pH 7.4). In our previous studies [9] on drug release
from crosslinked chitosan-alanine beads, it is
observed that the drug release in basic medium is
higher than in acidic medium. It is also observed
that at fixed concentration of crosslinker, the drug
release increases with an increase in chitosan con-
centration, reaches a maxima, followed by its
decrease. The drug release response increases to
‘peak’ maxima (>9.0·10–4 g/ml) at the intermedi-
ate value of concentration of chitosan (0.42 g) and
at somewhat higher concentration of crosslinker
(15.5%). This may be due to the fact that a high
concentration of chitosan results in a denser matrix,
which causes reduced degree of swelling of beads.
Consequently, the process of diffusion is slowed
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Figure 4. Contour plots (2D) showing the influence of
concentration of chitosan (X1) and concentration
of glutaraldehyde (X2) on drug release a) Y(2),
b) Y(7.4) for pH 2 and pH 7.4, respectively
Table 4. Comparison of the calculated and experimental response values for the formulations other than the design values
Table 5. Summary of results in analyzing lack of fit (LOF)
Chitosan
[g]
Glutaraldehyde
(10 ml) [%]
Drug (CPM)
[mg]
Response time
[hrs]
Calculated response
(·10–4) [g/ml]
Experimental response
(·10–4) [g/ml] Absolute
error
(X1) (X2) (X3) (X4) Y(2) Y(7.4) Y(2) Y(7.4)
0.1 06.25 100 3 – 8.45 – 8.49 0.04
0.3 0 100 5 – 9.99 – 9.91 –0.08
0.3 06.25 025 5 7.35 – 7.34 – –0.01
0.3 18.80 100 6 7.83 – 7.85 – 0.02
ANOVA for response surface quadratic model (drug release in pH = 2.0)
Source Sum of squares DF Mean square F value P
Model 11.12 14 0.794 13.584 < 0.0001
Residual 00.87684 15 0.05846
Lack of fit 00.87634 10 0.08763 08.636
Pure error 00.00051 05 0.0001
Cor total 11.9936 29
ANOVA for response surface quadratic model (drug release in pH = 7.4)
Source Sum of squares DF Mean square F value P
Model 09.34 14 0.667 11.485 < 0.0001
Residual 00.87092 15 0.05806
Lack of fit 00.86989 10 0.08698 04.209
Pure error 00.00103 05 0.00020
Cor total 10.2067 29down due to the decreased level of penetration of
solvent, which leads to decreased release of drug.
Bayomi et al. [1], Genta et al. [2] and Acikgöz et
al. [23] also observed that there is a significant
increase in drug release, when a more porous
matrix having low concentration of chitosan was
used.
The effects of concentration of chitosan, X1 and
concentration of drug, X3 on drug release in acidic
Y(2) and basic Y(7.4) media are plotted as contour
and shown in Figure 5. The amount of drug release
increases with the drug concentration in beads at
fixed level of chitosan concentration. The drug
release is maximum at nearly intermediate value of
concentration of chitosan, X1 = 0.42 g and a ‘rising
ridge’ is observed corresponding to this point.
According to Gupta and Kumar [7] and Kumar and
Gupta [8], the total amount of drug released from
the beads loaded with a higher concentration of
drug is found to be higher in comparison to the
beads loaded with a lower amount of CPM. At the
higher level of concentration of chitosan, the con-
centration of alanine is less. As a result of which,
the intermediate space between the different layers
of matrix is less causing lesser degree of swelling
and hence, the amount of drug release is minimum.
Figure 5b indicates that the drug release response is
similar, but higher in basic medium as compared to
drug release in acidic medium. Response to drug
release increases to ‘peak’ maxima (>9.2·10–4 g/ml)
corresponding to concentration of chitosan, X1 =
0.42 g and concentration of drug, X2 = 100 mg.
Figure 6 illustrates the effect of concentration of
chitosan, X1 and response time, X4 on drug release.
The response time has the similar effect on drug
release in acidic and basic media. In both the cases
Y(2) and Y(7.4), the ‘rising ridge’ is observed corre-
sponding to concentration of chitosan, X1 = 0.42 g,
similar to the studied effect of concentration of chi-
tosan, X1 and concentration of drug, X3 on drug
release in acidic medium Y(2) in Figure 4a. At the
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Figure 5. Contour plots (2D) showing the influence of
concentration of chitosan (X1) and concentration
of drug (X3) on drug release a) Y(2), b) Y(7.4)
for pH 2 and pH 7.4, respectively
Figure 6. Contour plots (2D) showing the influence of
concentration of chitosan (X1) and response time
(X4) on drug release a) Y(2), b) Y(7.4) for pH 2
and pH 7.4, respectivelyintermediate values of drug release time, the drug
release in acidic medium Y(2) = 7.45·10–4 g/ml and
in basic medium Y(7.4) = 9.07·10–4 g/ml. It is fur-
ther observed that the effect of response time is
more in acidic medium than in basic medium at
fixed level of concentration of chitosan.
The effects of concentration of crosslinker, X2 and
concentration of drug, X3 on drug release are
depicted in Figure 7. Minimum drug release is
found to be lying between the percentage of glu-
taraldehyde 9.8–20%, corresponding to lower
range of concentration of drug i.e. 0–41 mg. At the
lower values of percentage of crosslinker, the drug
release Y(2) increases linearly with the concentra-
tion of drug. The nature of response behavior
changes to non-linear at higher concentration of
crosslinker. Figure 7b observes the ‘region of max-
ima’ i.e. 9.4·10–4 g/ml for the drug release lying
between the high level of concentration of drug
(100 mg) and low level of crosslinker (approxi-
mately 3%). At the lower values of drug load, the
release of drug decreases linearly with an increase
in the percentage of crosslinker. The nature of drug
release behavior changes from linear to nonlinear at
the intermediate and higher values of drug load.
The effect of concentration of drug seems to be
more pronounced as compared with that of
crosslinker.
Figure 8 describes the effect of percentage of
crosslinker,  X2 and response time, X4 on drug
release. Contour plots in Figure 8a show the
‘region of minimum’ for concentration of the
released drug. The amount of drug release is mini-
mum (6.6·10–4 g/ml) at higher values of glutaralde-
hyde (18.8%) and at initial response time. At the
fixed response time, as the concentration of glu-
taraldehyde decreases, the response behavior
changes to linear. In Figure 8b, drug release
decreases linearly with percentage of crosslinker.
As the percentage of crosslinker increases, the pen-
etration of solvent in to the matrix becomes diffi-
cult. Thus, the degree of swelling decreases, result-
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Figure 7. Contour plots (2D) showing the influence of
concentration glutaraldehyde (X2) and concen-
tration of drug (X3) on drug release a) Y(2),
b) Y(7.4) for pH 2 and pH 7.4, respectively
Figure 8. Contour plots (2D) showing the influence of
concentration glutaraldehyde (X2) and response
time (X4) on drug release a) Y(2), b) Y(7.4) for
pH 2 and pH 7.4, respectivelying in decreased rate of drug release. At the fixed
value of crosslinker, as the response time increases,
the drug release increases linearly because swelling
is function of time.
The effects of concentration of drug, X3 and
response time, X4 on drug release are shown in Fig-
ure 9. In Figure 9a, the drug release response sur-
face is ‘hillside’ and varies in linear fashion with
increasing concentration of drug as well as
response time in acidic medium. However, the
effect of response time seems to be more effective
as compared to that of drug concentration. The
maximum amount of drug release is 8.4·10–4 g/ml
at the higher values of concentration of drug and
response time. In the basic medium, the drug
release response is a linear function for the early
values of concentration of drug and at all the values
of response time as shown in Figure 9b. The
response behavior becomes non linear at the higher
values of concentration of drug.
Figure 10 shows a linear correlation plots between
the actual and predicted response variables. The
linear correlation plots drawn between actual and
predicted responses demonstrate reasonable values
of R2 (i.e. for Y(2) R2 = 0.927 and for Y(7.4) R2 =
0.915). The R-square (correlation coefficient) value
provides a measure of how much of the variability
in the observed response values can be explained
by the experimental factors and their interactions.
A good model explains most of the variations in the
response. The closer the value of R-square to 1.0,
the stronger the model and the better are the
response predictions. Hence, high values of
R-square indicate significant lack of fit (P< 0.0001)
in both the cases.
The residual plots showing homogeneity of data for
drug release are plotted in Figure 11. All the exper-
imental data points are uniformly distributed
around the mean of response variable showing the
scatter of the residuals versus actual response val-
ues.
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Figure 9. Contour plots (2D) showing the influence of
concentration of drug (X3) and response time
(X4) on drug release a) Y(2), b) Y(7.4) for pH 2
and pH 7.4, respectively
Figure 10. Linear correlation plots between actual and
predicted response a) Y(2), b) Y(7.4) for pH 2
and pH 7.4, respectively4. Conclusions
Optimization of drug release from chitosan-alanine
crosslinked beads using RSM, central composite
design, is performed. On the basis of analysis of
variance (ANOVA), a second order model is estab-
lished, describing the effect of the amount of chi-
tosan (X1), the percentage of crosslinker i.e. glu-
taraldehyde (X2), the concentration of drug loading
(X3) and the time of drug release (X4) on drug
release response. The data obtained, based on
designed formulations, is fitted in second order
model for drug release in acidic and basic media.
Both the polynomials are found to be statistically
significant (P< 0.0001), as determined by ANOVA.
It is observed from the probability data of both the
models that the probability values of the coeffi-
cients of X1, X2, X3 and X4 are less than 0.1, which
is a significant value. It implies that all the four
independent variables have great influence on the
drug release response. ANOVA is used to evaluate
the adequacy of the fitted model. The prediction
from the model and the experimental results in this
study conform to each other quite well, indicating
the validity of the model. The obtained equations
are plotted as contour. The increase in percentage
of crosslinker and concentration of chitosan
reduces the drug release response due to the forma-
tion of highly dense matrix. From the data obtained
and contour plots, it may be concluded that the con-
centration of alanine has tremendous effect on the
swelling and drug release properties of the matrix.
As the concentration of alanine (which acts as
spacer) increases, the density of the matrix
decreases resulting in an increase in drug release. In
all the cases, the drug release is maximum for chi-
tosan concentration, X1 = 0.42 g (Figures 4–6). The
optimum drug level that can be loaded into the
matrix corresponding to maximum drug release in
basic medium is 100 mg (Figures 5b, 7b and 9b). It
is observed that the concentration of drug has pro-
nounced effect on drug release as compared to the
concentration of crosslinker. For the predicted
models, the range of percentage of glutaraldehyde
for optimum drug release is 10–18% (Figures 4
and 8a). In general, the response time has shown a
linear effect on drug release. As the response time
increases, the percentage of swelling of the matrix
increases and hence, the drug release increases lin-
early. It can be concluded that the response surface
methodology (RSM) can be successfully used to
optimize the drug release from chitosan–alanine
crosslinked beads loaded with CPM.
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